Comparison of the digene hybrid capture 2 and Roche cobas 4800 HPV tests for detection of CIN2+in a referral population in Japan

被引:10
|
作者
Sasagawa, Toshiyuki [1 ]
Maehama, Toshiyuki [2 ]
Osaka, Yasuhiro [1 ]
Sakamoto, Jinichi [1 ]
Shibata, Takeo [1 ]
Fujita, Satoko [1 ]
Takakura, Masahiro [1 ]
Takagi, Hiroaki [1 ]
机构
[1] Kanazawa Med Univ, Dept Obstet & Gynecol, Uchinada, Ishikawa, Japan
[2] Tomishiro Cent Hosp, Dept Obstet & Gynecol, Tomishiro City, Okinawa, Japan
关键词
cervical cancer screening; cervical intraepithelial neoplasia (CIN); cobas HPV test (cobas); HPV genotyping; human papillomavirus (HPV); hybrid capture-2 (HC2); CERVICAL INTRAEPITHELIAL NEOPLASIA; HUMAN-PAPILLOMAVIRUS INFECTIONS; RISK HUMAN-PAPILLOMAVIRUS; CANCER; WOMEN; DNA; SAMPLES; ASSAYS;
D O I
10.1002/jmv.25025
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To examine validity of the hybrid capture-2 and cobas 4800 HPV tests, 396 women including 188 women visiting for cancer screening, and 208 referral cases were examined with both HPV tests and the liquid-based cervical Pap test. Concordant results between the HPV assays were observed in 333 cases (coincident rates; 84.1%, kappa value; 0.682). The sensitivity for CIN2+ was 98.6% (69/70) and 82.9% (58/70) for HC2 and cobas 4800 (McNemar's test; P=0.0026). The sensitivity for CIN3+ was 97.2% (35/36) and 83.3% (30/36) (Not significant, P=0.0736). The specificities for CIN2+ or CIN3+ did not differ between the tests. The HPV16, 52, 18, 31, and 58 were the most common types in CIN2+ cases. Reasonable sensitivity for HPV52, and cross-hybridization with some probable high-risk HPV type such as HPV82 explain the higher sensitivity of HC2 than cobas 4800 in detection of CIN2+ in a referral population in Japan.
引用
收藏
页码:972 / 980
页数:9
相关论文
共 50 条
  • [1] Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial
    Darrel A. Cook
    Wendy Mei
    Laurie W. Smith
    Dirk J. van Niekerk
    Kathy Ceballos
    Eduardo L. Franco
    Andrew J. Coldman
    Gina S. Ogilvie
    Mel Krajden
    BMC Cancer, 15
  • [2] Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial
    Cook, Darrel A.
    Mei, Wendy
    Smith, Laurie W.
    van Niekerk, Dirk J.
    Ceballos, Kathy
    Franco, Eduardo L.
    Coldman, Andrew J.
    Ogilvie, Gina S.
    Krajden, Mel
    BMC CANCER, 2015, 15
  • [3] Comparison of Digene Hybrid Capture 2 and Roche cobas 4800 Human Papilloma Virus Assays
    Mendiola, J.
    Ikier, D.
    Roushar, B.
    Schrauth, J.
    Reinartz, J.
    Grutkoski, P.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 718 - 718
  • [4] Transition from Hybrid Capture 2 to Cobas 4800 in Hpv detection: sensitivity and specificity for Cin2+in two time periods
    Bottari, Fabio
    Boveri, Sara
    Iacobone, Anna Daniela
    Gulmini, Chiara
    Igidbashian, Sarah
    Cassatella, Maria Cristina
    Landoni, Fabio
    Sandri, Maria Teresa
    INFECTIOUS DISEASES, 2018, 50 (07) : 554 - 559
  • [5] Comparison of Sensitivity and Specificity for Hybrid Capture 2 and Cobas 4800 in Detecting HPV for CIN2+Patients
    Harbhajanka, Aparna
    Yan, Mingfei
    Bomeisl, Philip
    Michael, Claire
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 363 - 363
  • [6] Comparison of Sensitivity and Specificity for Hybrid Capture 2 and Cobas 4800 in Detecting HPV for CIN2+Patients
    Harbhajanka, Aparna
    Yan, Mingfei
    Bomeisl, Philip
    Michael, Claire
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 363 - 363
  • [7] Comparison of the PANArray HPV Genotyping Chip Test with the Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of HPV in ASCUS Women
    Ki, Eun Young
    Lee, Yoon Kyung
    Lee, Ahwon
    Park, Jong Sup
    YONSEI MEDICAL JOURNAL, 2018, 59 (05) : 662 - 668
  • [8] Comparison of the Roche Cobas® 4800 HPV assay to Digene Hybrid Capture 2, Roche Linear Array and Roche Amplicor for Detection of High-Risk Human Papillomavirus Genotypes in Women undergoing treatment for cervical dysplasia
    Phillips, Samuel
    Garland, Suzanne M.
    Tan, Jeffery H.
    Quinn, Michael A.
    Tabrizi, Sepehr N.
    JOURNAL OF CLINICAL VIROLOGY, 2015, 62 : 63 - 65
  • [9] Comparison of Aptima and hybrid capture-2 HPV tests and Pap test in the referral population in Japan
    Kuroki, Hiroko
    Sakamoto, Jinichi
    Shibata, Takeo
    Takakura, Masahiro
    Sasagawa, Toshiyuki
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (08) : 5076 - 5083
  • [10] COMPARISON OF COBAS® 4800 HPV ASSAY TO DIGENE HYBRID CAPTURE 2, ROCHE LINEAR ARRAY, AND AMPLICOR IN THE DETECTION OF HIGH-RISK HUMAN PAPILLOMAVIRUS GENOTYPES IN WOMEN WITH PREVIOUS ABNORMAL PAP SMEARS
    Tabrizi, S. N.
    Phillips, S.
    Garland, S. M.
    SEXUALLY TRANSMITTED INFECTIONS, 2013, 89 : A357 - A357